Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice
Source abstract
Abstract
BACKGROUND: Curcumin possesses significant anti-atherosclerosis properties. Lipocalin-2 (LCN2) is already known as one of the most promising biomarkers of atherosclerosis. However, research on the effect of curcumin on regulating LCN2 expression in atherogenesis is very limited. The aim of the study was to investigate whether curcumin could alleviate atherosclerosis in ApoE-/- mice by down-regulating LCN2 expression. METHODS: Fifty apolipoprotein E knockout (ApoE-/-) mice were fed with a western diet for 12 weeks and randomly divided into five groups: model group (Mod), positive control group (Lov, with 30 mg/kg/d lovastatin), three curcumin groups (CurL, CurM and CurH, with 40, 60 and 80 mg/kg/d curcumin), while 10 C57BL/6J mice were fed with a standard mouse chow diet as a control group (Con). LCN2 in serum and aorta, biomarkers of serum lipid and inflammation were determined and the plaque area of the atherosclerosis lesions was quantified. RESULTS: CurM and CurH group were significantly lower than Mod group in terms of serum LCN2, lipid and inflammatory cytokine levels, plaque area and LCN2 expression in atherosclerotic lesions, similar to lovastatin treatment. CONCLUSIONS: Our findings indicate that dietary curcumin ameliorates western diet-induced atherosclerosis in ApoE-/- mice, which is related to LCN2 down-regulation, anti-hyperlipidemia effect as well as the inhibition of inflammation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Acute Kidney Injury Research · Ginkgo biloba and Cashew Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Cardiology, Affiliated Hospital, Jiangxi University of Traditional Chinese Medicine, Nanchang, China
Institute of Cardiovascular Disease, Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
References (26)
Show source-provided references
1. A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase10.1016/0014-5793(92)81511-J ↗
2. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase10.1016/S0021-9258(18)82217-7 ↗
3. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron10.1038/nature03104 ↗
4. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study10.1016/j.jacc.2011.11.046 ↗
5. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention10.1016/j.jacc.2012.04.017 ↗
6. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort10.1161/ATVBAHA.114.303718 ↗
7. 10.1371/journal.pone.006660710.1371/journal.pone.0066607 ↗
8. Molecular MRI of murine atherosclerotic plaque targeting NGAL: A protein associated with unstable human plaque characteristics10.1093/cvr/cvq340 ↗
9. Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits10.1016/j.nutres.2014.09.001 ↗
10. Curcumin modulates macrophage polarization through the inhibition of the toll-like receptor 4 expression and its signaling pathways10.1159/000430126 ↗
11. Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration10.1002/mnfr.201100818 ↗
12. A practical approach to using mice in atherosclerosis research
13. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification10.7326/0003-4819-139-2-200307150-00013 ↗
14. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL10.1074/jbc.M106089200 ↗
15. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome10.5152/akd.2014.5513 ↗
16. Oxidized phospholipids trigger atherogenic inflammation in murine arteries10.1161/01.ATV.0000153106.03644.a0 ↗
17. Atheroprotective mechanisms of HDL10.1016/S0021-9150(99)00065-9 ↗
18. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism10.1002/mnfr.201100440 ↗
19. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor10.1161/01.RES.0000115557.25127.8D ↗
20. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice10.1016/j.atherosclerosis.2004.11.016 ↗
21. Strategies for vascular disease prevention: The role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA(2)) and lipoprotein(a) (Lp(a))10.1016/j.beem.2014.01.003 ↗
22. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages10.1210/me.2007-0420 ↗
23. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: A randomized controlled trial10.1016/j.jnutbio.2013.09.013 ↗
24. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage10.1007/s00011-014-0758-9 ↗
25. 10.1186/s12967-014-0266-210.1186/s12967-014-0266-2 ↗
26. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice10.1016/j.atherosclerosis.2013.10.016 ↗